°íÁß¼ºÁö¹æÇ÷Áõ°ú º¹ºÎºñ¸¸ÀÌ °ü»óµ¿¸Æ ÁßÀç¼úÀ» ½Ã¼ú¹ÞÀº ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚÀÇ ÀÓ»ó°æ°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ
Clinical Impact of High Triglycerides and Central Obesity in Patients with Acute Myocardial Infarction who Underwent Percutaneous Coronary Intervention

´ëÇѳ»°úÇÐȸÁö 2014³â 86±Ç 2È£ p.169 ~ p.178

ÇѼö°æ(Han Soo-Gyoung) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
Á¤¸íÈ£(Jeong Myung-Ho) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
ÀÌÁ¤¾Ö(Rhee Jung-Ae) - Àü³²´ëÇб³ Àǰú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
ÃÖÁø¼ö(Choi Jin-Su) - Àü³²´ëÇб³ Àǰú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
À̱âÈ«(Lee Ki-Hong) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
¹Ú±ÙÈ£(Park Keun-Ho) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
½ÉµÎ¼±(Sim Doo-Sun) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
È«¿µÁØ(Hong Young-Joon) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
±èÁÖÇÑ(Kim Ju-Han) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
¾È¿µ±Ù(Ahn Young-Keun) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
Á¶Á¤°ü(Cho Jeong-Gwan) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
¹ÚÁ¾Ãá(Park Jong-Chun) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ
°­Á¤Ã¤(Kang Jung-Chaee) - Àü³²´ëÇб³º´¿ø ½ÉÀå¼¾ÅÍ

Abstract

¸ñÀû: Àα¸ÀÇ °í·ÉÈ­ ¹× »ýȰ ½À°üÀÇ º¯È­·Î ½É±Ù°æ»öÁõ, Çù½ÉÁõ µîÀÇ °ü»óµ¿¸Æ ÁúȯÀº ÁÖ¿ä »ç¸Á¿øÀÎÀÌ µÇ°í ÀÖ´Ù.
°ü»óµ¿¸Æ ÁúȯÀÇ À§ÇèÀÎÀڷδ Èí¿¬, °íÇ÷¾Ð, ´ç´¢º´, ÀÌ»óÁöÇ÷Áõ, ºñ¸¸ µîÀÌ Àß ¾Ë·ÁÁ® ÀÖÀ¸¸ç ÀÌ·¯ÇÑ À§ÇèÀÎÀÚ¸¦ Á¶ÀýÇÏ´Â °ÍÀÌ °ü»óµ¿¸Æ ÁúȯÀÇ ¿¹¹æ°ú Ä¡·á¿¡ ÇʼöÀûÀÌ´Ù. ¶ÇÇÑ °ü»óµ¿¸Æ ÁúȯÀÇ Ä¡·á·Î¼­ °æÇÇÀû °ü»óµ¿¸Æ ÁßÀç¼ú(percutaneous coronary intervention, PCI)ÀÌ ¸¹ÀÌ ½ÃÇàµÇ°í ÀÖ´Ù. ÀÌ ¿¬±¸¿¡¼­´Â ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ PCI ÈÄ Áß¼ºÁö¹æÀÇ ¼öÄ¡¿Í º¹ºÎºñ¸¸ÀÇ À¯¹«¿¡ µû¸¥ ÀÓ»óÀû °æ°ú¸¦ ÆÄ¾ÇÇϰíÀÚ ÇÏ¿´´Ù.

¹æ¹ý: 2006³â 1¿ùºÎÅÍ 2010³â 12¿ù±îÁö Àü³²´ëÇб³º´¿ø¿¡ ³»¿øÇÑ ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ Áß¿¡¼­ PCI ½ÃÇà ÈÄ 1³â°£ Ãß
Àû°üÂûÇÏ¿´´ø ȯÀÚ 2,751¿¹(Æò±Õ³ªÀÌ 63.7 ¡¾ 12.1¼¼)¸¦ ´ë»óÀ¸·Î ÇÏ¿´´Ù. ÀÌ È¯ÀÚµéÀ» Áß¼ºÁö¹æÀÇ ¼öÄ¡¿Í º¹ºÎºñ¸¸ÀÇ À¯¹«¿¡ µû¶ó Áß¼ºÁö¹æÀÌ 200 mg/dL ¹Ì¸¸ÀÌ¸ç º¹ºÎºñ¸¸ÀÌ ¾ø´Â ±ºÀ» Ia±º 1,217¸í(63.9 ¡¾ 11.9¼¼, ³²ÀÚ: 87.6%), Áß¼ºÁö¹æÀÌ 200 mg/dL ¹Ì¸¸ÀÌ¸ç º¹ºÎºñ¸¸ÀÌ ÀÖ´Â ±ºÀ» Ib±º 1,203¸í(65.4 ¡¾ 11.6¼¼, ³²ÀÚ: 55.5%), Áß¼ºÁö¹æÀÌ 200 mg/dL ÀÌ»óÀÌ¸ç º¹ºÎºñ¸¸ÀÌ ¾ø´Â ±ºÀ» IIa±º 132¸í(56.3 ¡¾ 12.0¼¼, ³²ÀÚ: 97.0%), Áß¼ºÁö¹æÀÌ 200 mg/dL ÀÌ»óÀÌ¸ç º¹ºÎºñ¸¸ÀÌ ÀÖ´Â ±ºÀ» IIb±º 199¸í(57.3 ¡¾ 12.7¼¼, ³²ÀÚ: 66.3%)À¸·Î ºÐ·ùÇÏ¿© °¢ ±º °£ÀÇ ÀÓ»ó°æ°ú¿Í ÁÖ¿ä ½ÉÀå»ç°Ç ¹ß»ýÀ» ºÐ¼®ÇÏ¿´´Ù.

°á°ú: ´ë»ó ȯÀÚ¸¦ 1³â°£ ÃßÀû°üÂûÇÑ °á°ú ÁÖ¿ä ½ÉÀå»ç°ÇÀº 502¸í(18.2%)¿¡¼­ ¹ß»ýÇÏ¿´À¸¸ç »ç¸ÁÀº 303¸í(11.0%)¿¡
¼­ ¹ß»ýÇÏ¿´´Ù. º¹ºÎºñ¸¸ÀÌ Àִ ȯÀÚ±º¿¡¼­ °íÇ÷¾Ð°ú ´ç´¢º´ÀÌ ´õ ¸¹¾ÒÀ¸¸ç ÃÑ ÄÝ·¹½ºÅ׷Ѱú Àú¹Ðµµ Áö´Ü¹é ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡ ¿ª½Ã º¹ºÎºñ¸¸ÀÌ ÀÖ´Â ±º¿¡¼­ ´õ ³ô¾Ò´Ù. º´¿ø ³» ÇÕº´ÁõÀ̳ª »ç¸Á·üÀº ³× ±×·ì °£¿¡ Â÷À̰¡ ¾ø¾ú°í 1³â°£ÀÇ ½ÉÀå»ç°Ç ¹ß»ý ºñÀ²µµ °¢ ±º °£¿¡ À¯ÀÇÇÑ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾ÒÀ¸¸ç ¿¬·É ¹× ¼ºº°À» º¸Á¤ÇÑ ÈÄ¿Í ´Ùº¯·® º¸Á¤ ÈÄ¿¡µµ À¯ÀÇÇÑ Â÷À̰¡ ¾ø¾ú´Ù.

°á·Ð: PCI¸¦ ¹ÞÀº ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ Áß¼ºÁö¹æÀÇ ¼öÄ¡³ª º¹ºÎºñ¸¸ÀÇ À¯¹«¿¡ µû¶ó º´¿ø ³» ÇÕº´Áõ ¹ß»ýÀ̳ª
1³â°£ÀÇ ÁÖ¿ä ½ÉÀå»ç°Ç ¹ß»ý µîÀÇ ÀÓ»óÀû °æ°ú¿¡ ÀÖ¾î Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù.
Background/Aims: Dyslipidemia and obesity are risk factors for the development of acute myocardial infarction (AMI) that affect the clinical outcomes in patients.

Methods: We analyzed 2,751 consecutive AMI patients who underwent percutaneous coronary intervention (PCI) (mean age, 63.7 ¡¾ 12.1 years). The patients were divided into four groups based on serum triglyceride levels and central obesity [Group Ia: triglycerides < 200 mg/dL and (-) central obesity; Group Ib: triglyceride < 200 mg/dL and (+) central obesity; Group IIa: triglyceride ¡Ã 200 mg/dL and (-) central obesity; Group IIb: triglyceride ¡Ã 200 mg/dL and (+) central obesity]. In-hospital outcome was defined as in-hospital mortality and complications. One-year clinical outcome was compared and defined as the composite of 1-year major adverse cardiac events (MACE), including death, recurrent MI, and target vessel revascularization.

Results: Total MACE developed in 502 patients (18.2%), while 303 patients (11.0%) died prior to the 1-year follow-up visit. In-hospital complications and in-hospital mortality were not different among the four groups. One-year clinical outcomes based on triglyceride levels (Group I vs. Group II) were not different. In addition, there were no differences in clinical outcomes in patients with a triglyceride level < 200 mg/dL, regardless of central obesity. One-year MACE rates were not significantly different among the four groups.

Conclusions: There was no significant difference in the 1-year MACE rate based on the triglyceride level and presence of central obesity in patients with AMI who underwent PCI.

Ű¿öµå

±Þ¼º ½É±Ù°æ»öÁõ, Áß¼ºÁö¹æ, º¹ºÎºñ¸¸, »ç¸Á·ü
Acute myocardial infarction, Obesity, Triglyceride, Mortality
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå